DCGI initiates review of pharma manufacturing standards to ensure drug quality and safety

India's drug regulator, the Drug Controller General of India (DCGI), plans to review pharmaceutical manufacturing standards in order to ensure the quality, safety, and efficacy of drugs. The DCGI will meet with pharma industry associations to discuss reviewing Good Manufacturing Practices (GMP) for pharma companies. The government aims to upgrade Schedule M, which lays down GMP, to international standards.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/q92ipw4
via IFTTT